SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Apricus Biosciences
An SI Board Since September 2014
Posts SubjectMarks Bans Symbol
2026 18 0 APRI
Emcee:  mokelumne river Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1851Barbara T gets the axe !apriluv-4/15/2016
1850Thanks SLmokelumne river-4/12/2016
1849I emailed IR yesterday to try to get updated information about the Sandoz GermanStrong Long24/12/2016
1848I did like the statement on page 14 that >no additional clinical studies (arephoenix_rising-4/11/2016
1847MI, good model and I agree. What I am also hopeful about is that the "pendmokelumne river-4/11/2016
1846James - I have my model for 2016 at them having expenses of $15M. So the low endMirror Image-4/11/2016
1845NOTE, the corporate presentation states that Vitaros has been "Approved in Mirror Image-4/11/2016
1844Thanks MI, I agree with you on the "keys" to the $25M treasure chest.mokelumne river-4/11/2016
1843Eman/MI, every time I think about profitability based on Vitaros, I come up withmokelumne river-4/11/2016
1842Glad that you cleared that up for me. In my mind, I had Richard Pascoe saying weMirror Image-4/11/2016
1841>If Allergan elects to opt-in, Apricus may receive up to a total of $25 milliMirror Image-4/11/2016
1840MI, he said they were on track to do 500K units per quarter, not necessarily Q1 eico20-4/11/2016
1839Now that you have me reading the corporate presentation, it states on page 13: mokelumne river-4/11/2016
1838With my eyes going back and forth between your list and the 10K: Sandoz has Finmokelumne river-4/11/2016
1837New Corporate Presentation ir.apricusbio.com One of their slides has a list ofMirror Image-4/11/2016
1836I am not unhappy that Gillespie is gone. Morton is now Senior VP, Chief Businmokelumne river-4/6/2016
1835Morton still aboard , Gillespie gone.oldcoach19-4/6/2016
1834also, Pascoe said to me recently that he was ready to take off the gloves with Seico20-4/6/2016
1833good points MI, they don't have anything else to work on now, so Q3 could beeico20-4/6/2016
1832As far as how much would be saved by deciding to list the companies shares on thMirror Image-4/6/2016
1831Thank you MI and Eman for your analyses. I recall thinking that management shoumokelumne river-4/6/2016
1830 I doubt they have the NDA submitted by Sept, more like Nov / Dec, alot of shareMirror Image-4/6/2016
1829good point MI on the obvious reference to Sarrisa and Aspire at least, let'seico20-4/6/2016
1828I would love to see Sarissa appoint someone to the board. I would really like tMirror Image-4/6/2016
1827good point MI, they should appoint Denner/rep to the board, I doubt they have theico20-4/6/2016
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News